Explore Eberhard Karls Universitt Tbingen Medizinische Fakultt's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Jul 24, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3054993Dec 4, 2019Permanent Gene Correction By Means Of Nucleotide-Modified Messenger Rna1